Relationship between IL-6 and COVID-19: to be considered during treatment

The detection and control of pro-inflammatory response is crucial in the early stages of viral infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global concern and optimal treatment has yet to be determined. Unknown response of treatment of COVID-19 is important during p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatansever, Hafize Seda, Becer, Eda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780788/
http://dx.doi.org/10.2217/fvl-2020-0168
_version_ 1783631570599411712
author Vatansever, Hafize Seda
Becer, Eda
author_facet Vatansever, Hafize Seda
Becer, Eda
author_sort Vatansever, Hafize Seda
collection PubMed
description The detection and control of pro-inflammatory response is crucial in the early stages of viral infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global concern and optimal treatment has yet to be determined. Unknown response of treatment of COVID-19 is important during patient monitoring. IL-6 is one of the key cytokines after activated macrophages. Therefore, control of systemic IL-6 levels in SARS-CoV-2 infected patients may be a parameter for COVID-19 disease. This review is focused on the induction of IL-6 after viral infections as a target molecule for monitoring cellular response.
format Online
Article
Text
id pubmed-7780788
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-77807882021-01-04 Relationship between IL-6 and COVID-19: to be considered during treatment Vatansever, Hafize Seda Becer, Eda Future Virol Special Report The detection and control of pro-inflammatory response is crucial in the early stages of viral infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global concern and optimal treatment has yet to be determined. Unknown response of treatment of COVID-19 is important during patient monitoring. IL-6 is one of the key cytokines after activated macrophages. Therefore, control of systemic IL-6 levels in SARS-CoV-2 infected patients may be a parameter for COVID-19 disease. This review is focused on the induction of IL-6 after viral infections as a target molecule for monitoring cellular response. Future Medicine Ltd 2020-12-24 2020-12 /pmc/articles/PMC7780788/ http://dx.doi.org/10.2217/fvl-2020-0168 Text en © 2020 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Special Report
Vatansever, Hafize Seda
Becer, Eda
Relationship between IL-6 and COVID-19: to be considered during treatment
title Relationship between IL-6 and COVID-19: to be considered during treatment
title_full Relationship between IL-6 and COVID-19: to be considered during treatment
title_fullStr Relationship between IL-6 and COVID-19: to be considered during treatment
title_full_unstemmed Relationship between IL-6 and COVID-19: to be considered during treatment
title_short Relationship between IL-6 and COVID-19: to be considered during treatment
title_sort relationship between il-6 and covid-19: to be considered during treatment
topic Special Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780788/
http://dx.doi.org/10.2217/fvl-2020-0168
work_keys_str_mv AT vatanseverhafizeseda relationshipbetweenil6andcovid19tobeconsideredduringtreatment
AT becereda relationshipbetweenil6andcovid19tobeconsideredduringtreatment

Ejemplares similares